BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32765079)

  • 1. Modulation of MnSOD and FoxM1 Is Involved in Invasion and EMT Suppression by Isovitexin in Hepatocellular Carcinoma Cells.
    Qiu Y; Cao X; Liu L; Cao X; Yuan Q; Li X; Cui Y; Xu C; Zou C; Ren K; Cao J
    Cancer Manag Res; 2020; 12():5759-5771. PubMed ID: 32765079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isovitexin reduces carcinogenicity and stemness in hepatic carcinoma stem-like cells by modulating MnSOD and FoxM1.
    Cao X; Liu L; Yuan Q; Li X; Cui Y; Ren K; Zou C; Chen A; Xu C; Qiu Y; Quan M; Zhang J; Cao J; Chen X
    J Exp Clin Cancer Res; 2019 Jun; 38(1):264. PubMed ID: 31208440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isovitexin Suppresses Stemness of Lung Cancer Stem-Like Cells through Blockage of MnSOD/CaMKII/AMPK Signaling and Glycolysis Inhibition.
    Liu F; Yuan Q; Cao X; Zhang J; Cao J; Zhang J; Xia L
    Biomed Res Int; 2021; 2021():9972057. PubMed ID: 34195288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein inhibits lung cancer cell stem-like characteristics by modulating MnSOD and FoxM1 expression.
    Fu Z; Cao X; Liu L; Cao X; Cui Y; Li X; Quan M; Ren K; Chen A; Xu C; Qiu Y; Chen X; Wang Z; Cao J
    Oncol Lett; 2020 Sep; 20(3):2506-2515. PubMed ID: 32782570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loganic acid regulates the transition between epithelial and mesenchymal-like phenotypes by alleviating MnSOD expression in hepatocellular carcinoma cells.
    Kim NY; Ha IJ; Um JY; Kumar AP; Sethi G; Ahn KS
    Life Sci; 2023 Mar; 317():121458. PubMed ID: 36731649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isovitexin Inhibits Stemness and Induces Apoptosis in Hepatocellular Carcinoma SK-Hep-1 Spheroids by Upregulating miR-34a Expression.
    Xu C; Cao X; Cao X; Liu L; Qiu Y; Li X; Zhou L; Ning Y; Ren K; Cao J
    Anticancer Agents Med Chem; 2020; 20(14):1654-1663. PubMed ID: 32329692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daidzin targets epithelial-to-mesenchymal transition process by attenuating manganese superoxide dismutase expression and PI3K/Akt/mTOR activation in tumor cells.
    Yang MH; Jung SH; Um JY; Kumar AP; Sethi G; Ahn KS
    Life Sci; 2022 Apr; 295():120395. PubMed ID: 35181309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isovitexin attenuates tumor growth in human colon cancer cells through the modulation of apoptosis and epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway.
    Zhu H; Zhao N; Jiang M
    Biochem Cell Biol; 2021 Dec; 99(6):741-749. PubMed ID: 34219464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line.
    Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1.
    Yu CP; Yu S; Shi L; Wang S; Li ZX; Wang YH; Sun CJ; Liang J
    Mol Med Rep; 2017 Oct; 16(4):5181-5188. PubMed ID: 28849004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isovitexin Suppresses Cancer Stemness Property And Induces Apoptosis Of Osteosarcoma Cells By Disruption Of The DNMT1/miR-34a/Bcl-2 Axis.
    Liang X; Xu C; Cao X; Wang W
    Cancer Manag Res; 2019; 11():8923-8936. PubMed ID: 31686915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in lung adenocarcinomas.
    Chen PM; Wu TC; Shieh SH; Wu YH; Li MC; Sheu GT; Cheng YW; Chen CY; Lee H
    Mol Cancer Res; 2013 Mar; 11(3):261-71. PubMed ID: 23271813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of MnSOD and FoxM1 is Involved in Invasion and EMT Suppression by Isovitexin in Hepatocellular Carcinoma Cells [Retraction].
    Cancer Manag Res; 2022; 14():1473-1474. PubMed ID: 35469135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARK5 promotes invasion and migration in hepatocellular carcinoma cells by regulating epithelial-mesenchymal transition.
    Ye Z; Chen X; Chen X
    Oncol Lett; 2018 Feb; 15(2):1511-1516. PubMed ID: 29434843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,3,5,6-Tetramethylpyrazine Targets Epithelial-Mesenchymal Transition by Abrogating Manganese Superoxide Dismutase Expression and TGFβ-Driven Signaling Cascades in Colon Cancer Cells.
    Jung YY; Mohan CD; Eng H; Narula AS; Namjoshi OA; Blough BE; Rangappa KS; Sethi G; Kumar AP; Ahn KS
    Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-630 Suppresses Epithelial-to-Mesenchymal Transition by Regulating FoxM1 in Gastric Cancer Cells.
    Feng J; Wang X; Zhu W; Chen S; Feng C
    Biochemistry (Mosc); 2017 Jun; 82(6):707-714. PubMed ID: 28601080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor FOXM1 promotes hepatocellular carcinoma malignant progression through activation of the WNT pathway by binding to SETDB1.
    Kong J; Xu S; Deng Z; Wang Y; Zhang P
    Tissue Cell; 2023 Oct; 84():102186. PubMed ID: 37556918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells.
    Bao B; Wang Z; Ali S; Kong D; Banerjee S; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
    J Cell Biochem; 2011 Sep; 112(9):2296-306. PubMed ID: 21503965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer.
    Wang Y; Yao B; Wang Y; Zhang M; Fu S; Gao H; Peng R; Zhang L; Tang J
    Int J Mol Med; 2014 Jun; 33(6):1514-22. PubMed ID: 24676803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.